Skip to content

Clinical trials

Phase 3 Obesity trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 3 Country / region: Italy Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20041
20052
20062
20071
20112
20131
20141
20152
20171
20182
20223
20233
20242
20258
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting17
Active, not recruiting8
Terminated3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S17
Eli Lilly and Company9
Sanofi5
Amgen4
Bambino Gesù Hospital and Research Institute2
Hoffmann-La Roche2
AstraZeneca1
Boehringer Ingelheim1
Federico II University1
Istituto Auxologico Italiano1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity46
Overweight21
Diabetes Mellitus, Type 26
Nutrition Disorders5
Cardiovascular Diseases3
Diabetes Mellitus3
Dyslipidemias3
Body Weight2
Heart Failure2
Non-alcoholic Fatty Liver Disease2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.